AGA clinical practice update on diagnosis and management of immune checkpoint inhibitor colitis and hepatitis: expert review
M Dougan, Y Wang, A Rubio-Tapia, JK Lim - Gastroenterology, 2021 - Elsevier
Background & Aims Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
[引用][C] AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
M Dougan, Y Wang, A Rubio-Tapia, JK Lim - Gastroenterology, 2021 - cir.nii.ac.jp
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor
Colitis and Hepatitis: Expert Review | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Colitis and Hepatitis: Expert Review | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
M Dougan, Y Wang, A Rubio-Tapia… - …, 2021 - mdanderson.elsevierpure.com
Background & Aims: Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
M Dougan, Y Wang, A Rubio-Tapia… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background & aims Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.
M Dougan, Y Wang, A Rubio-Tapia, JK Lim - Gastroenterology, 2020 - europepmc.org
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor
Colitis and Hepatitis: Expert Review. - Abstract - Europe PMC Sign in | Create an account …
Colitis and Hepatitis: Expert Review. - Abstract - Europe PMC Sign in | Create an account …
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
M Dougan, Y Wang, A Rubio-Tapia, JK Lim - Gastroenterology, 2021 - gastrojournal.org
Background & Aims Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
[PDF][PDF] CLINICAL PRACTICE UPDATE
M Dougan, Y Wang - Gastroenterology, 2021 - ibd.umfcv.ro
BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
[PDF][PDF] CLINICAL PRACTICE UPDATE
M Dougan, Y Wang - Gastroenterology, 2021 - giboardreview.com
BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) have transformed the treatment
landscape for oncology, leading to durable remissions in a subset of patients, but also a …
landscape for oncology, leading to durable remissions in a subset of patients, but also a …